These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 31050763)

  • 1. Effect of Cognitive Behavioral Therapy on Clinical Disease Course in Adolescents and Young Adults With Inflammatory Bowel Disease and Subclinical Anxiety and/or Depression: Results of a Randomized Trial.
    van den Brink G; Stapersma L; Bom AS; Rizopolous D; van der Woude CJ; Stuyt RJL; Hendriks DM; van der Burg JAT; Beukers R; Korpershoek TA; Theuns-Valks SDM; Utens EMWJ; Escher JC
    Inflamm Bowel Dis; 2019 Nov; 25(12):1945-1956. PubMed ID: 31050763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of Disease-Specific Cognitive Behavioral Therapy on Anxiety, Depression, and Quality of Life in Youth With Inflammatory Bowel Disease: A Randomized Controlled Trial.
    Stapersma L; van den Brink G; van der Ende J; Szigethy EM; Beukers R; Korpershoek TA; Theuns-Valks SDM; Hillegers MHJ; Escher JC; Utens EMWJ
    J Pediatr Psychol; 2018 Oct; 43(9):967-980. PubMed ID: 29850915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of cognitive-behavioral therapy on quality of life, anxiety, and depressive symptoms among patients with inflammatory bowel disease: A multicenter randomized controlled trial.
    Bennebroek Evertsz' F; Sprangers MAG; Sitnikova K; Stokkers PCF; Ponsioen CY; Bartelsman JFWM; van Bodegraven AA; Fischer S; Depla ACTM; Mallant RC; Sanderman R; Burger H; Bockting CLH
    J Consult Clin Psychol; 2017 Sep; 85(9):918-925. PubMed ID: 28857595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive-Behavioural Therapy for Inflammatory Bowel Disease: 24-Month Data from a Randomised Controlled Trial.
    Mikocka-Walus A; Bampton P; Hetzel D; Hughes P; Esterman A; Andrews JM
    Int J Behav Med; 2017 Feb; 24(1):127-135. PubMed ID: 27432441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of disease-specific cognitive-behavioural therapy on depression, anxiety, quality of life and the clinical course of disease in adolescents with inflammatory bowel disease: study protocol of a multicentre randomised controlled trial (HAPPY-IBD).
    van den Brink G; Stapersma L; El Marroun H; Henrichs J; Szigethy EM; Utens EM; Escher JC
    BMJ Open Gastroenterol; 2016; 3(1):e000071. PubMed ID: 26966551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized efficacy trial of two psychotherapies for depression in youth with inflammatory bowel disease.
    Szigethy E; Bujoreanu SI; Youk AO; Weisz J; Benhayon D; Fairclough D; Ducharme P; Gonzalez-Heydrich J; Keljo D; Srinath A; Bousvaros A; Kirshner M; Newara M; Kupfer D; DeMaso DR
    J Am Acad Child Adolesc Psychiatry; 2014 Jul; 53(7):726-35. PubMed ID: 24954822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychological Outcomes of a Cognitive Behavioral Therapy for Youth with Inflammatory Bowel Disease: Results of the HAPPY-IBD Randomized Controlled Trial at 6- and 12-Month Follow-Up.
    Stapersma L; van den Brink G; van der Ende J; Szigethy EM; Groeneweg M; de Bruijne FH; Hillegers MHJ; Escher JC; Utens EMWJ
    J Clin Psychol Med Settings; 2020 Sep; 27(3):490-506. PubMed ID: 31506853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bi-directionality of Brain-Gut Interactions in Patients With Inflammatory Bowel Disease.
    Gracie DJ; Guthrie EA; Hamlin PJ; Ford AC
    Gastroenterology; 2018 May; 154(6):1635-1646.e3. PubMed ID: 29366841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive-behavioural therapy has no effect on disease activity but improves quality of life in subgroups of patients with inflammatory bowel disease: a pilot randomised controlled trial.
    Mikocka-Walus A; Bampton P; Hetzel D; Hughes P; Esterman A; Andrews JM
    BMC Gastroenterol; 2015 May; 15():54. PubMed ID: 25934170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness of cognitive behavioral therapy on the quality of life of patients with inflammatory bowel disease: multi-center design and study protocol (KL!C- study).
    Bennebroek Evertsz' F; Bockting CL; Stokkers PC; Hinnen C; Sanderman R; Sprangers MA
    BMC Psychiatry; 2012 Dec; 12():227. PubMed ID: 23237076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatigue management in patients with IBD: a randomised controlled trial.
    Vogelaar L; van't Spijker A; Timman R; van Tilburg AJ; Bac D; Vogelaar T; Kuipers EJ; van Busschbach JJ; van der Woude CJ
    Gut; 2014 Jun; 63(6):911-8. PubMed ID: 23884638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical disease activity is associated with anxiety and depressive symptoms in adolescents and young adults with inflammatory bowel disease.
    van den Brink G; Stapersma L; Vlug LE; Rizopolous D; Bodelier AG; van Wering H; Hurkmans PCWM; Stuyt RJL; Hendriks DM; van der Burg JAT; Utens EMWJ; Escher JC
    Aliment Pharmacol Ther; 2018 Aug; 48(3):358-369. PubMed ID: 29897134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of 'IBD-Specific Cognitive Behavioural Therapy' for Patients with Inflammatory Bowel Diseases with Poor Mental Quality of Life, Anxiety and Depression.
    Bennebroek Evertsz' F; Bockting CL; Braamse A; van Dissel MNM; Duijvestein M; Kager LM; Kool M; Löwenberg M; Mares W; Nieuwkerk P; Sipkema HA; Young Z; Knoop H
    J Clin Psychol Med Settings; 2024 Jun; 31(2):258-278. PubMed ID: 38281306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
    Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
    Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a Cognitive Behavioral Therapy Intervention Trial to Improve Disease Outcomes in Children with Inflammatory Bowel Disease.
    Levy RL; van Tilburg MA; Langer SL; Romano JM; Walker LS; Mancl LA; Murphy TB; Claar RL; Feld SI; Christie DL; Abdullah B; DuPen MM; Swanson KS; Baker MD; Stoner SA; Whitehead WE
    Inflamm Bowel Dis; 2016 Sep; 22(9):2134-48. PubMed ID: 27542131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-help Cognitive Behavioral Therapy Improves Health-Related Quality of Life for Inflammatory Bowel Disease Patients: A Randomized Controlled Effectiveness Trial.
    Hunt MG; Loftus P; Accardo M; Keenan M; Cohen L; Osterman MT
    J Clin Psychol Med Settings; 2020 Sep; 27(3):467-479. PubMed ID: 31025253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mood disorders in inflammatory bowel disease: relation to diagnosis, disease activity, perceived stress, and other factors.
    Goodhand JR; Wahed M; Mawdsley JE; Farmer AD; Aziz Q; Rampton DS
    Inflamm Bowel Dis; 2012 Dec; 18(12):2301-9. PubMed ID: 22359369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive behaviour therapy for distress in people with inflammatory bowel disease: A benchmarking study.
    Jordan C; Hayee B; Chalder T
    Clin Psychol Psychother; 2019 Jan; 26(1):14-23. PubMed ID: 30207003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis.
    Klingberg E; Strid H; Ståhl A; Deminger A; Carlsten H; Öhman L; Forsblad-d'Elia H
    Arthritis Res Ther; 2017 Feb; 19(1):21. PubMed ID: 28148281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized controlled trial of transdiagnostic group treatments for primary care patients with common mental disorders.
    Ejeby K; Savitskij R; Ost LG; Ekbom A; Brandt L; Ramnerö J; Asberg M; Backlund LG
    Fam Pract; 2014 Jun; 31(3):273-80. PubMed ID: 24642702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.